Trial Outcomes & Findings for Vacuum-Assisted Dressings (V-AD) in the Management of Open Chest Wounds (NCT NCT02803164)
NCT ID: NCT02803164
Last Updated: 2021-09-29
Results Overview
The total number of days of receiving NWPT
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
21 participants
Primary outcome timeframe
12 month follow up
Results posted on
2021-09-29
Participant Flow
Participant milestones
| Measure |
Intervention
Treatment of wound with Vacuum-assisted dressing.
Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
|
Historical Control
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques
|
|---|---|---|
|
Overall Study
STARTED
|
10
|
11
|
|
Overall Study
COMPLETED
|
10
|
11
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Intervention
n=10 Participants
Treatment of wound with Vacuum-assisted dressing.
Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
|
Control Group
n=11 Participants
Historical chest wound treatment.
|
Total
n=21 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
61 years
n=10 Participants
|
62 years
n=11 Participants
|
62 years
n=21 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=10 Participants
|
1 Participants
n=11 Participants
|
8 Participants
n=21 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=10 Participants
|
10 Participants
n=11 Participants
|
13 Participants
n=21 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
10 participants
n=10 Participants
|
11 participants
n=11 Participants
|
21 participants
n=21 Participants
|
PRIMARY outcome
Timeframe: 12 month follow upPopulation: Data not collected or analyzed for the Historical Control arm. This arm did not receive the NWPT.
The total number of days of receiving NWPT
Outcome measures
| Measure |
Intervention
n=10 Participants
Treatment of wound with Vacuum-assisted dressing.
Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
|
Historical Control
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques.
|
|---|---|---|
|
Duration of Negative Pressure Wound Therapy (NWPT)
|
8 Days
Interval 2.0 to 29.0
|
—
|
SECONDARY outcome
Timeframe: 12 monthsThe total number of days to wound closure
Outcome measures
| Measure |
Intervention
n=10 Participants
Treatment of wound with Vacuum-assisted dressing.
Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
|
Historical Control
n=11 Participants
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques.
|
|---|---|---|
|
Wound Closure
|
7 Days
Interval 4.0 to 49.0
|
18 Days
Interval 4.0 to 179.0
|
SECONDARY outcome
Timeframe: 12 monthsThe total number of days in hospital
Outcome measures
| Measure |
Intervention
n=10 Participants
Treatment of wound with Vacuum-assisted dressing.
Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
|
Historical Control
n=11 Participants
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques.
|
|---|---|---|
|
Length of Hospital Stay
|
6 Days
Interval 1.0 to 43.0
|
25 Days
Interval 3.0 to 152.0
|
Adverse Events
Intervention
Serious events: 2 serious events
Other events: 2 other events
Deaths: 2 deaths
Historical Control
Serious events: 11 serious events
Other events: 8 other events
Deaths: 1 deaths
Serious adverse events
| Measure |
Intervention
n=10 participants at risk
Treatment of wound with Vacuum-assisted dressing.
Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
|
Historical Control
n=11 participants at risk
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques
|
|---|---|---|
|
Infections and infestations
Sepsis
|
10.0%
1/10 • Number of events 1 • 1 year
|
63.6%
7/11 • Number of events 7 • 1 year
|
|
Cardiac disorders
Major cardiac event
|
0.00%
0/10 • 1 year
|
9.1%
1/11 • Number of events 1 • 1 year
|
|
Respiratory, thoracic and mediastinal disorders
Air Embolism
|
0.00%
0/10 • 1 year
|
9.1%
1/11 • Number of events 1 • 1 year
|
|
Respiratory, thoracic and mediastinal disorders
Reintubation
|
0.00%
0/10 • 1 year
|
18.2%
2/11 • Number of events 2 • 1 year
|
|
Respiratory, thoracic and mediastinal disorders
Acute Respiratory Distress Syndrome
|
0.00%
0/10 • 1 year
|
9.1%
1/11 • Number of events 1 • 1 year
|
|
Renal and urinary disorders
Acute kidney failure
|
0.00%
0/10 • 1 year
|
9.1%
1/11 • Number of events 1 • 1 year
|
|
Respiratory, thoracic and mediastinal disorders
Hemothorax
|
10.0%
1/10 • Number of events 1 • 1 year
|
9.1%
1/11 • Number of events 1 • 1 year
|
Other adverse events
| Measure |
Intervention
n=10 participants at risk
Treatment of wound with Vacuum-assisted dressing.
Wound Vacuum-assisted dressing: Management of chronic open chest wounds with V-AD assisted dressing.
|
Historical Control
n=11 participants at risk
Retrospective review of subjects medical records with open chest wounds who were treated with the traditional treatment techniques
|
|---|---|---|
|
Cardiac disorders
Atrial fibrillation
|
0.00%
0/10 • 1 year
|
45.5%
5/11 • Number of events 5 • 1 year
|
|
Respiratory, thoracic and mediastinal disorders
pneumonia
|
10.0%
1/10 • Number of events 1 • 1 year
|
27.3%
3/11 • Number of events 3 • 1 year
|
|
General disorders
Wound dehiscence
|
10.0%
1/10 • Number of events 1 • 1 year
|
0.00%
0/11 • 1 year
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place